Non-invasive tools for liver injury after chemotherapy
Part of Digestive system clinical trials.
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have received platinum chemotherapy for a solid tumor
- You do not have cirrhosis (scarring of the liver) confirmed by biopsy
- You have not had a liver transplant
- You do not have advanced liver cancer beyond Milan criteria
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a rare liver condition called porto-sinusoidal vascular disorder (PSVD), where blood flow in the liver is abnormal but no cirrhosis is present. Researchers want to learn what causes it and how it affects patients over time.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
Hear when a new Non-Cirrhotic Portal Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.